Polewski et al. [48] confirmed that the cystine/glutamate antiporter system (SLC7A11) is upregulated in glioma, and the overexpression of SLC7A11 enhances the stemness phenotype of glioma stem cells (see Figure 1). This evidence concerns the gene SLC7A11 and central nervous system cancer.